Evoke Pharma is committed to making a difference in the lives of patients who suffer from diabetic
gastroparesis and is pleased to offer this educational event exploring the disease burden and innovative
approaches to managing the condition.

Join us for a discussion about how GLP-1 medications can help prevent worsening of chronic kidney disease

AstraZenaca is committed to helping providers and patients understand the importance of reducing exacerbations to reduce cardiopulmonary risk and mortality in COPD.